Grant: Engage Grants Program
York University
$25,000.00
Determination of percentage antigen adsorption in vaccine drug formulation.
FY 2016-17
Summary
Production of vaccine drug formulation is a multi-million dollar commercial activity. To operate on an industrial scale normally requires the manufacturing of high efficiency drug products which is typically obtained by the addition of adjuvants in drug formulations, but percentage adsorption of antigens vary dramatically among different drug formulations. Since immunogenicity is directly linked with percentage antigen adsorption, it is extremely critical to develop a method for the quantification of adsorbed antigens in the final drug product. Determination of percentage antigen adsorption would require the quantification of both free and adsorbed antigens in the drug product. Sanofi Pasteur is attempting to develop a method for quantification of free antigens using AQUA method coupled with LC-MS. The method is currently being optimized to overcome the matrix effect. The quantification of adsorbed antigens is still a challenge and we propose to desorb antigens using various reagents and temperature conditions to breakdown the strong electrostatic interactions between antigens and adjuvant. The drug product will be centrifuged to isolate free antigen. The pellet containing adsorbed antigen will be resuspended and treated with reagents such as cetylpyridinium chloride, sodium citrate dihydrate, sodium phosphate dibasic, guanidine HCl, urea and succinate. Once the antigens are successfully desorbed, the free antigens will be digested with trypsin and quantified by LC-MS method being developed by Sanofi Pasteur. This method will be an advancement in pharmaceutical research that will enhance drug efficacy in patients and bring increased visibility and recognition to Canadian research within the world-wide scientific community.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
500609-2016
Name nom
Ifa, Demian
Department département
Chemistry
Organization id
38
Institution établissement
York University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Determination of percentage antigen adsorption in vaccine drug formulation.
Keyword
NSERC
Application summary
Production of vaccine drug formulation is a multi-million dollar commercial activity. To operate on an industrial scale normally requires the manufacturing of high efficiency drug products which is typically obtained by the addition of adjuvants in drug formulations, but percentage adsorption of antigens vary dramatically among different drug formulations. Since immunogenicity is directly linked with percentage antigen adsorption, it is extremely critical to develop a method for the quantification of adsorbed antigens in the final drug product. Determination of percentage antigen adsorption would require the quantification of both free and adsorbed antigens in the drug product. Sanofi Pasteur is attempting to develop a method for quantification of free antigens using AQUA method coupled with LC-MS. The method is currently being optimized to overcome the matrix effect. The quantification of adsorbed antigens is still a challenge and we propose to desorb antigens using various reagents and temperature conditions to breakdown the strong electrostatic interactions between antigens and adjuvant. The drug product will be centrifuged to isolate free antigen. The pellet containing adsorbed antigen will be resuspended and treated with reagents such as cetylpyridinium chloride, sodium citrate dihydrate, sodium phosphate dibasic, guanidine HCl, urea and succinate. Once the antigens are successfully desorbed, the free antigens will be digested with trypsin and quantified by LC-MS method being developed by Sanofi Pasteur. This method will be an advancement in pharmaceutical research that will enhance drug efficacy in patients and bring increased visibility and recognition to Canadian research within the world-wide scientific community.